
"I think our performance has clearly shown that Apollo has the ability, the agility to handle both Covid and non-Covid situations. This quarter, we successfully separated the non-Covid cases and handled them with excellent clinical outcomes. Moving into the second quarter, we believe we will be able to keep doing this."
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2W4SN8M
via
IFTTT
0 comments:
Post a Comment